Kathleen Jee is an Ophthalmology physician affiliated with Cleveland Eye Clinic. OpenAlex indexes 35 publications with 616 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
2 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
68.3%Prostaglandin Analog25.4%Latanoprost93%Lumigan7%Part D<11 patientsAminoglycoside Antibacterial18.9%Neomycin-Polymyxin-Dexameth100%Part D≥172 patients+ 4 more classes in this area
Musculoskeletal
18.5%Cyclooxygenase Inhibitor18.5%Ketorolac Tromethamine100%Part D≥168 patientsCardiovascular
6.9%Beta blocker6.9%Timolol Maleate100%Part D≥41 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Abstract Th0071: Angiopoietin-like 4 synergizes with vascular endothelial growth factor to contribute to the development of diabetic macular edema
Arteriosclerosis Thrombosis and Vascular Biology
2025 - VEGF inhibition increases expression of HIF-regulated angiogenic genes by the RPE limiting the response of wet AMD eyes to aflibercept
Proceedings of the National Academy of Sciences
2024 - Targeting hypoxia-inducible factors with 32-134D safely and effectively treats diabetic eye disease in mice
Journal of Clinical Investigation
2023
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”